Paper10072524
Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
Powell JD and 2 others. J Immunol, 1999. Cited by 228 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. Papers, record 10072524. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10072524
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle Proteins | Major topic |
| Clonal Anergy | Major topic |
| Immunosuppressive Agents | Major topic |
| Sirolimus | Major topic |
| T-Lymphocytes | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Calcium-Calmodulin-Dependent Protein Kinases | |
| Cell Cycle | |
| Cells, Cultured | |
| Cyclin-Dependent Kinase Inhibitor p27 | |
| Cyclosporine | |
| Humans | |
| Interferon-gamma | |
| Interleukin-2 | |
| Interleukin-3 | |
| Lymphocyte Activation | |
| Microtubule-Associated Proteins | |
| Receptors, Antigen, T-Cell | |
| Ribosomal Protein S6 Kinases |
Source PubMed
Cited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41648580 | Glucose availability tunes latent CD8+ T cell expansion potential through a mitogen-independent, mTOR-dependent regulatory switch. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648580 | PubMed |
| 41576164 | CD318 expression defines a novel subset of human CD8+ regulatory T cells. | Sci Adv | 2026 | https://conductscience.org/library/papers/41576164 | PubMed |
| 40707326 | Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy? | Trends Immunol | 2025 | https://conductscience.org/library/papers/40707326 | PubMed |
| 40042298 | Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome. | Clin Microbiol Rev | 2025 | https://conductscience.org/library/papers/40042298 | PubMed |
| 39575238 | The role of hypoxic microenvironment in autoimmune diseases. | Front Immunol | 2024 | https://conductscience.org/library/papers/39575238 | PubMed |
| 39211048 | Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype. | Front Immunol | 2024 | https://conductscience.org/library/papers/39211048 | PubMed |
| 38948198 | Suppression of P53 Pathway is an Important Factor Inducing Acute Graft-versus-Host Disease Through T Cell Activation Based on Bioinformatics Analysis. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/38948198 | PubMed |
| 37980949 | Vaccines for immune tolerance against autoimmune disease. | Adv Drug Deliv Rev | 2023 | https://conductscience.org/library/papers/37980949 | PubMed |
| 37954599 | Memory regulatory T cells in pregnancy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37954599 | PubMed |
| 37779156 | Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37779156 | PubMed |
| 37251381 | Molecular treatment trajectories within psoriatic T lymphocytes: a mini review. | Front Immunol | 2023 | https://conductscience.org/library/papers/37251381 | PubMed |
| 37196768 | IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer. | J Biol Chem | 2023 | https://conductscience.org/library/papers/37196768 | PubMed |
| 37111784 | mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4+CD57+ T Cells In Vivo and In Vitro. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111784 | PubMed |
| 36817420 | Pathogenesis and treatment of Sjogren's syndrome: Review and update. | Front Immunol | 2023 | https://conductscience.org/library/papers/36817420 | PubMed |
| 36672607 | Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression. | Biomedicines | 2022 | https://conductscience.org/library/papers/36672607 | PubMed |
| 36420486 | Essential role of 4E-BP1 for lymphocyte activation and proliferation in the adaptive immune response of Nile tilapia. | Fish Shellfish Immunol Rep | 2021 | https://conductscience.org/library/papers/36420486 | PubMed |
| 36399071 | Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo. | Blood | 2022 | https://conductscience.org/library/papers/36399071 | PubMed |
| 34846643 | Cancer metabolism and tumor microenvironment: fostering each other? | Sci China Life Sci | 2022 | https://conductscience.org/library/papers/34846643 | PubMed |
| 33802831 | Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33802831 | PubMed |
| 33670268 | Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33670268 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL3 | 3562 | PubTator's text mining | https://conductscience.org/library/genes/3562 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10072524
GET https://conductscience.org/api/papers/v1/10072524/cited_by?page=2